<DOC>
	<DOC>NCT00148421</DOC>
	<brief_summary>Comparing two drugs to treat subjects with non-myeloid malignancies receiving multicycle chemotherapy.</brief_summary>
	<brief_title>Study for the Treatment of Anemia in Patients With Non-myeloid Malignancies Receiving Multicycle Chemotherapy.</brief_title>
	<detailed_description>The purpose of this study is to compare the effect of darbepoetin alfa and Epoetin alfa for the treatment of anemia in subjects with non-myeloid malignancies receiving multicycle chemotherapy.</detailed_description>
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Darbepoetin alfa</mesh_term>
	<mesh_term>Epoetin Alfa</mesh_term>
	<criteria>Planned chemotherapy treatment Anemia (hemoglobin concentration less than or equal to 11.0 g/dL) Adequate renal and liver function Subjects must provide written informed consent Known history of seizure disorder Known primary hematologic disorder causing anemia other than nonmyeloid malignancies Unstable / uncontrolled cardiac condition Clinically significant inflammatory disease Known positive test for HIV infection Neutralizing antibodies to rHuEPO Epoetin alfa or darbepoetin alfa therapy within 4 weeks before randomization Received any investigational drug or device within 30 days before randomization Pregnant or breast feeding Not using adequate contraceptive precautions Previously randomized into this study Known hypersensitivity to recombinant mammalianderived product Concerns for subject's compliance</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Non-myeloid malignancy</keyword>
	<keyword>Chemotherapy-induced anemia</keyword>
</DOC>